Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Tracking overspending involves straightforward methods like category budgets and regular reviews. Get started with easy steps to monitor and adjust your budget.
17,487 articlesA late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Berkshire Hathaway's Greg Abel recently bought Macy's stock, sparking questions about value and strategy. This in-dep...
Ripple unveils its 2025 Impact Report, revealing more than $70 million in donations this year and a broader global pu...
Memory prices and AI data demands have put Micron and Sandisk in the spotlight. This piece breaks down what’s driving...
Three graduates walk away from a formal program after a brief stint in the office. They build Evergreen Edge Asset Pa...
Even careful savers slip into traps that quietly erode returns. This guide lays out six big money mistakes to avoid a...
Apple just pulled back after a strong run, leaving investors wondering if now is the time to buy. This article uses h...
Set a weekly ritual to translate headlines into a smarter portfolio. This Thursday reads guide shows you how to pick ...
Tech stocks can swing wildly, but a meaningful pullback often reveals entry points for patient investors. This guide ...
Meta and Amazon are at the forefront of a trillion-dollar Big Tech capex surge, led by AI infrastructure and data-cen...
Policy clarity clears the path for road ahead build-to-rent projects, lifting investor confidence. Still, the pace of...
Micron has bounced around the market, but its long-term growth story is coming into sharper focus. This article expla...